Manesh Patel, MD, and his colleague Rymer delve into the most impactful and interesting trials presented at the Fall cardiovascular meetings.
Heart Beats
Manesh Patel, MD, kicks off his first podcast by discussing HFpEF findings in EMPEROR-Preserved, the GUIDE-HF trial and more with his Duke colleague.
The SGLT-2 inhibitor drug class is expanding into treatment indications experts could not have predicted. Learn how DAPA-HF contributed to the understanding of dapagliflozin.
The first episode of the Heart Trials podcast series focuses on new ACC 2021 research into aspirin dosages for reduced cardiovascular event risk.
Advertisement
Advertisement
Trending on HCPLive
1
Medical Ethics Unpacked: The History and Ethics of Brain Death
2
Pigmentation Pipeline: Vitiligo and Melasma Treatment Advances
3
Saroglitazar and the Evolving PBC Treatment Landscape, With Raj Vuppalanchi, MD
4
Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation
5